BridgeMD
New treatment option for Necrotizing Enterocolitis
Official title Probiotic Supplementation in Extremely Preterm Infants in Scandinavia
ClinicalTrials.gov ID: NCT05604846
What this study is testing
- What it's testing
- The primary aim of this research is to determine whether supplementation with probiotics during the first weeks of life reduces the risk of necrotizing enterocolitis (NEC) and neonatal mortality and is safe to use among extremely preterm (EPT) infants born before gestational week 28. P: The study population include EPT infants (n= 1620) born at six tertiary neonatal units in Sweden and four units in Denmark.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 28
You may be able to join if
- -All extremly preterm infants born beween gestational age 22+0 to 27+6
You likely can't join if
- Patients with severe complications and low chance of survival detected wihin the first 72 hours of life
- Patients with major congenital-anomalies
- Patients included in other treatment trials with the same or overlapping oucome measures.
The study team makes the final eligibility decision.
Where it's taking place
- Solna, Stockholm County, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 weeks to 28 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Solna, Stockholm County, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.